<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Biotechnology Archives - Salvia GmbH</title>
	<atom:link href="https://salvia.de/en/category/biotechnology/feed/" rel="self" type="application/rss+xml" />
	<link>https://salvia.de/en/category/biotechnology/</link>
	<description>Wir unterstützen heute innovative Unternehmen von morgen mit Kapital, Know-how und Netzwerk.</description>
	<lastBuildDate>Tue, 25 Nov 2025 14:34:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.4.8</generator>

<image>
	<url>https://salvia.de/wp-content/uploads/2021/05/cropped-salvia-icon-square-520x520-whitebg-32x32.png</url>
	<title>Biotechnology Archives - Salvia GmbH</title>
	<link>https://salvia.de/en/category/biotechnology/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Bambusa Therapeutics</title>
		<link>https://salvia.de/en/bambusa-therapeutics/</link>
		
		<dc:creator><![CDATA[Salvia GmbH]]></dc:creator>
		<pubDate>Thu, 12 Sep 2024 12:02:16 +0000</pubDate>
				<category><![CDATA[Active Investments]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Venture Investments]]></category>
		<guid isPermaLink="false">https://salvia.de/?p=1602</guid>

					<description><![CDATA[<p>Bambusa Therapeutics is a rapidly growing biotechnology company specializing in developing transformative inflammatory and immunological therapeutics. Based in the vibrant Boston Seaport area, our mission is to advance the field of immunology with cutting-edge solutions.</p>
<p>The post <a href="https://salvia.de/en/bambusa-therapeutics/">Bambusa Therapeutics</a> appeared first on <a href="https://salvia.de/en/">Salvia GmbH</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Bambusa Therapeutics is a rapidly growing biotechnology company specializing in developing transformative inflammatory and immunological therapeutics. Based in the vibrant Boston Seaport area, our mission is to advance the field of immunology with cutting-edge solutions.</p>
<p>The post <a href="https://salvia.de/en/bambusa-therapeutics/">Bambusa Therapeutics</a> appeared first on <a href="https://salvia.de/en/">Salvia GmbH</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Aldevron</title>
		<link>https://salvia.de/en/aldevron/</link>
		
		<dc:creator><![CDATA[R R]]></dc:creator>
		<pubDate>Mon, 31 May 2021 10:12:07 +0000</pubDate>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Closed Investments]]></category>
		<guid isPermaLink="false">https://salvia.de/2021/05/31/aldevron/</guid>

					<description><![CDATA[<p>Aldevron is a leading company in the field of bioscience. The company offers contract manufacturing and scientific services and specialises in the production of plasmid DNA, messenger RNA and proteins.</p>
<p>The post <a href="https://salvia.de/en/aldevron/">Aldevron</a> appeared first on <a href="https://salvia.de/en/">Salvia GmbH</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Aldevron is a leading company in the field of bioscience. The company offers contract manufacturing and scientific services and specialises in the production of plasmid DNA, messenger RNA and proteins.</p>
<p>The post <a href="https://salvia.de/en/aldevron/">Aldevron</a> appeared first on <a href="https://salvia.de/en/">Salvia GmbH</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Ganymed Pharmaceuticals AG</title>
		<link>https://salvia.de/en/ganymed-pharmaceuticals-ag/</link>
		
		<dc:creator><![CDATA[R R]]></dc:creator>
		<pubDate>Mon, 31 May 2021 10:07:31 +0000</pubDate>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Closed Investments]]></category>
		<guid isPermaLink="false">https://salvia.de/2021/05/31/ganymed-pharmaceuticals-ag/</guid>

					<description><![CDATA[<p>The company, established as a spin-off from the Universities of Mainz and Zurich, develops safe and highly effective pharmaceuticals for the treatment of cancer.</p>
<p>The post <a href="https://salvia.de/en/ganymed-pharmaceuticals-ag/">Ganymed Pharmaceuticals AG</a> appeared first on <a href="https://salvia.de/en/">Salvia GmbH</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>The company, established as a spin-off from the Universities of Mainz and Zurich, develops safe and highly effective pharmaceuticals for the treatment of cancer.</p>
<p>The post <a href="https://salvia.de/en/ganymed-pharmaceuticals-ag/">Ganymed Pharmaceuticals AG</a> appeared first on <a href="https://salvia.de/en/">Salvia GmbH</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
